You are here
Alexandre PratDr. Prat discussed the selection of drugs for the treatment of multiple sclerosis.Therapy choices must be based on adequate disease control, safety, tolerability, adherence, safety monitoring and concomitant medication.
Mark S. FreedmanAccording to Professor Freedman, treatment of multiple sclerosis should delay or prevent the accumulation of permanent disability and should be evaluated over a prolonged time frame, with an absolute minimum of 2 years of therapy.
David BatesAccording to Professor Bates, many treatment options are now available for multiple sclerosis, but with varying benefit-risk profiles, fuelling further demand for new therapeutics.